• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].

作者信息

Ratschow R

出版信息

MMW Munch Med Wochenschr. 1976 Sep 3;118(36):1131-4.

PMID:823407
Abstract

Naftidrofuryl hydrogen oxalate was used for 4 1/2 years in 216 patients with chronic arterial occlusive disease in a surgical clinic. An increase of 1 to 10 times the walking distance could be obtained in over 77% of cases in Fontaine's stage II by a genuine combination treatment with active vascular muscle training and continuous intravenous drip lasting for an average of 28 days. The continuous drip treatment was made possible by a specially designed infusion rucksack 19% of the cases still showed a moderate effect on the walking capacity. By elimination of pain at rest and healing of trophic disorders, it was possible to transfer over 68% of the patients in Stages III and IV to Stage II.

摘要

相似文献

1
[Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
MMW Munch Med Wochenschr. 1976 Sep 3;118(36):1131-4.
2
[Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].静脉注射奈呋胺酯对动脉闭塞性疾病Ⅲ期和Ⅳ期患者微循环的影响
Vasa Suppl. 1988;24:33-7.
3
[Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].萘呋胺酯用于外周动脉闭塞性疾病Ⅲ期和Ⅳ期的治疗
Vasa Suppl. 1988;24:38-43.
4
[Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
J Mal Vasc. 1987;12(1):78-81.
5
[Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].[草酸萘呋胺酯治疗周围动脉闭塞性疾病的双盲研究]
Med Welt. 1979 Feb 16;30(7):269-72.
6
[Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].[静脉输注萘呋胺酯治疗肢体动脉疾病。临床与功能研究]
Therapie. 1974 Nov-Dec;29(6):915-23.
7
[Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].萘呋胺酯治疗动脉闭塞性疾病。口服给药的对照多中心双盲研究
Dtsch Med Wochenschr. 1984 May 11;109(19):745-50. doi: 10.1055/s-2008-1069267.
8
[Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].萘呋胺酯治疗下肢阻塞性动脉疾病
Minerva Cardioangiol. 1975 Oct;23(10):607-21.
9
Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.奈呋胺酯治疗慢性动脉疾病。一项对照多中心研究的结果。
Angiology. 1984 Nov;35(11):701-8. doi: 10.1177/000331978403501103.
10
[Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].[萘呋胺酯在外周动脉闭塞性疾病中的毛细血管显微镜检查效应]
Vasa Suppl. 1988;24:17-20.